Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters
Lei Li, Yoshikazu Honda‐Okubo, Jeremy Baldwin, Richard A. Bowen, Helle Bielefeldt‐Ohmann, Nikolai Petrovsky
Topics & Concepts
ImmunogenicityAdjuvantNeutralizing antibodyAntibodyAntigenImmune systemVirologyRecombinant DNAImmunologyTiterMedicineBiologyGeneBiochemistrySARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyCOVID-19 epidemiological studies